Amway’s 1Q14 results were in line with consensus and our estimates, as 1H is normally weaker than 2H. Revenue and earnings expanded due to stronger sales and lower operating costs. A first interim single-tier dividend of 10 sen per share was declared. Thus, we maintain our NEUTRAL call and MYR11.80 FV.
-
Within estimates. Amway’s 1Q14 sales and earnings increased by 4.6% and 10.3% y-o-y respectively. The growth in revenue was due to positive impact of sales and marketing programmes. Net profit improved amid the backdrop of stronger turnover and lower operating costs. Compared with 4Q13, revenue was up by 8% q-o-q, thanks to higher distributor productivity, which was driven by Amway’s sales and marketing programmes. However, net profit weakened by 11.9% q-o-q,largely due to lower operating expenses recorded in 4Q13.
-
Improved margins. The company’s 1Q14 gross margin weakenedslightly to 30.7% y-o-y from 30.8% while PBT margin trended higher by 80bps to 16.1% y-o-y. The latter was mainly attributed to lower overheads. Amway declared an interim single-tier dividend of 10 sen per share this quarter, similar to 1Q13.
-
Key risks. The key investment risks are: i) a decline in consumer spending power, ii) intensifying competition, iii) an unfavourable forex exchange rate (ie USD/MYR) during its annual pricing review, and iv) the company’s inability to pass on higher cost to its customers.
-
Maintain NEUTRAL. We leave our numbers unchanged, given the in line results. With its strong market presence and well -known brand names, we believe Amway is on track to deliver satisfactory res ults moving forward. FV remains at MYR11.80, based on dividend DDM valuation. We maintain our NEUTRAL call, as the stock is trading at a forward P/E of 18x, which is similar to its 3-year historical P/E. Amway’s dividend yield is still decent at >5%.
Company Profile
Amway is a leading multi-level marketing company in Malaysia.
Source: RHB